XBIO:Xenetic Biosciences Inc Snapshot | Charting | News | Options
$4.14 NASDAQ 8:01a ET
March 22 '24 		Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results ACCESSWIRE
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
     ACCESSWIRE

    FRAMINGHAM, MA / ACCESSWIRE / March 22, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat cancers, today reported its financial results for the year ended December 31, 2023.

    Full Story →

    Headline News
    More News →
    Day  7.25%Week  6.53%Month  2.59%More Charting →
    April 18 '24. Markets Closed.
    Last $4.14
    Day change   7.25%$0.28
    Open $3.92
    Gap at open $0.06
    Previous close $3.86
    Trading volume 7,906
    10 Day avg vol. 4,418
    Shares out. 1.5Mil
    Market cap. $6.4Mil
    Trading activity Above Avg.
    Previous data from yesterday, April 17 '24.

    Historical Price Performance
    3 month   19.14% 
    6 month   9.71% 
    1 year   20.08% 
    2 year   61.43% 

    Earnings
    Previous 12m -$2.70
    Next 12m Estimate -$3.43
    P/E ratio 1.5x
    Revenue 3Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.